Recruiting NA Primary Insomnia

Tests treatment safety and results for Primary Insomnia

Official title Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia

ClinicalTrials.gov ID: NCT06996171

What this study is testing

What is Magnesium glycinate?

Magnesium glycinate is an investigational medicine, being studied as a potential treatment for primary insomnia.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
Sleep is essential for our overall health and well-being, much like food and water. It plays a vital role in numerous bodily functions.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 40

You may be able to join if

  • Age 18-40 years
  • Gender: Male and Females (Non-pregnant \& Non lactating)
  • Diagnosed cases of primary insomnia according to following criteria:
  • Difficulty falling asleep, staying asleep or nonrestorative sleep
  • This difficulty is present despite adequate opportunity \& circumstance to sleep

You likely can't join if

  • Insomnia due to a known underlying cause
  • Any psychiatric illness
  • Active use of sedative hypnotics
See the full eligibility criteria
Who can join
  • Age 18-40 years
  • Gender: Male and Females (Non-pregnant \& Non lactating)
  • Diagnosed cases of primary insomnia according to following criteria:
  • Difficulty falling asleep, staying asleep or nonrestorative sleep
  • This difficulty is present despite adequate opportunity \& circumstance to sleep
  • This impairment in sleep is associated with daytime impairment or distress
  • This sleep difficulty occurs at least 3 times per week and has been a problem for at least 1 month
What rules you out
  • Insomnia due to a known underlying cause
  • Any psychiatric illness
  • Active use of sedative hypnotics

The study team makes the final eligibility decision.

Where it's taking place

  • Kharan, Punjab Province, Pakistan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 40 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Kharan, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.